Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The serpin solution; targeting thrombotic and thrombolytic serine proteases in inflammation.
Chen H, Davids JA, Zheng D, Bryant M, Bot I, van Berckel TJ, Biessen E, Pepine C, Ryman K, Progulski-Fox A, Kesavalu L, Moyer R, McFadden G, Lucas A. Chen H, et al. Among authors: davids ja. Cardiovasc Hematol Disord Drug Targets. 2013 Aug;13(2):99-110. doi: 10.2174/1871529x11313020003. Cardiovasc Hematol Disord Drug Targets. 2013. PMID: 23987998 Review.
Viral serpin therapeutics from concept to clinic.
Chen H, Zheng D, Davids J, Bartee MY, Dai E, Liu L, Petrov L, Macaulay C, Thoburn R, Sobel E, Moyer R, McFadden G, Lucas A. Chen H, et al. Methods Enzymol. 2011;499:301-29. doi: 10.1016/B978-0-12-386471-0.00015-8. Methods Enzymol. 2011. PMID: 21683260 Free PMC article. Review.
Serpins for diagnosis and therapy in cancer.
Zheng D, Chen H, Davids J, Bryant M, Lucas A. Zheng D, et al. Cardiovasc Hematol Disord Drug Targets. 2013 Aug;13(2):123-32. doi: 10.2174/1871529x11313020005. Cardiovasc Hematol Disord Drug Targets. 2013. PMID: 23988000 Review.
The serpin saga; development of a new class of virus derived anti-inflammatory protein immunotherapeutics.
Lucas A, Liu L, Dai E, Bot I, Viswanathan K, Munuswamy-Ramunujam G, Davids JA, Bartee MY, Richardson J, Christov A, Wang H, Macaulay C, Poznansky M, Zhong R, Miller L, Biessen E, Richardson M, Sullivan C, Moyer R, Hatton M, Lomas DA, McFadden G. Lucas A, et al. Among authors: davids ja. Adv Exp Med Biol. 2009;666:132-56. doi: 10.1007/978-1-4419-1601-3_11. Adv Exp Med Biol. 2009. PMID: 20054981 Review.
Myxomavirus-derived serpin prolongs survival and reduces inflammation and hemorrhage in an unrelated lethal mouse viral infection.
Chen H, Zheng D, Abbott J, Liu L, Bartee MY, Long M, Davids J, Williams J, Feldmann H, Strong J, Grau KR, Tibbetts S, Macaulay C, McFadden G, Thoburn R, Lomas DA, Spinale FG, Virgin HW, Lucas A. Chen H, et al. Antimicrob Agents Chemother. 2013 Sep;57(9):4114-27. doi: 10.1128/AAC.02594-12. Epub 2013 Jun 17. Antimicrob Agents Chemother. 2013. PMID: 23774438 Free PMC article.
Viral cross-class serpin inhibits vascular inflammation and T lymphocyte fratricide; a study in rodent models in vivo and human cell lines in vitro.
Viswanathan K, Bot I, Liu L, Dai E, Turner PC, Togonu-Bickersteth B, Richardson J, Davids JA, Williams JM, Bartee MY, Chen H, van Berkel TJ, Biessen EA, Moyer RW, Lucas AR. Viswanathan K, et al. Among authors: davids ja. PLoS One. 2012;7(9):e44694. doi: 10.1371/journal.pone.0044694. Epub 2012 Sep 26. PLoS One. 2012. PMID: 23049756 Free PMC article.
43 results